Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5771806

CN1CCN(C(=O)CCc2cnoc2-c2ccc(F)c(Cl)c2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.47
GRIN2B Q13224 3/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
MC4R P32245 8/20 0.37
HDAC4 P56524 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MC5R P33032 1/20 0.36
MC3R P41968 1/20 0.36
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
TNKS O95271 1/20 0.36
PARP1 P09874 1/20 0.36
PARP2 Q9UGN5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5776834 0.87 HTT (0.46) POLBKMT2AHPGDHDAC4HDAC6
Trifluoroacetic Acid SCHEMBL5773532 0.84 POLB (0.44) POLBKMT2AALDH1A1HPGDHDAC4
Trifluoroacetic Acid SCHEMBL5772282 0.83 LMNA (0.39) POLBGRIN2BKMT2ADPP4DPP8
SCHEMBL5773845 0.82 TNKS (0.40) POLBGRIN2BALDH1A1HPGDTNKS
SCHEMBL5774812 0.80 FFAR1 (0.42)
SCHEMBL5775627 0.80 KMT2A (0.49) MEN1KMT2AALDH1A1HPGDDPP4
SCHEMBL5775415 0.79 ENPP2 (0.40) GRIN2BDPP4DPP8DPP9DPP7
Trifluoroacetic Acid SCHEMBL5774077 0.79 POLB (0.51) POLBMEN1KMT2AALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL5776129 0.78 MEN1 (0.50) POLBMEN1KMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL5776836 0.78 PARP1 (0.44) MEN1KMT2AMC4RPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR POLB 3996/4885GRIN2B 2007/4885MEN1 2811/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 POLB 3909/4885GRIN2B 2374/4885MEN1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.